HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shilpa Chokshi Selected Research

Antiviral Agents (Antivirals)

1/2018Differential Expression of Immune Inhibitory Checkpoint Signatures on Antiviral and Inflammatory T Cell Populations in Chronic Hepatitis B.
1/2017Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients.
8/2014Truncated CXCL10 is associated with failure to achieve spontaneous clearance of acute hepatitis C infection.
6/2009Early viraemia clearance during antiviral therapy of chronic hepatitis C improves dendritic cell functions.
9/2008Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion.
1/2008Viral clearance or persistence after acute hepatitis C infection: interim results from a prospective study.
11/2005Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shilpa Chokshi Research Topics

Disease

11Fibrosis (Cirrhosis)
12/2023 - 04/2013
6Infections
11/2023 - 01/2008
6Inflammation (Inflammations)
11/2023 - 01/2016
6Chronic Hepatitis B
12/2022 - 11/2005
5Liver Diseases (Liver Disease)
11/2023 - 01/2020
5Hepatocellular Carcinoma (Hepatoma)
10/2023 - 06/2008
4Fatty Liver
01/2024 - 01/2022
4Alcoholic Hepatitis
01/2022 - 06/2018
4Viremia
09/2008 - 11/2005
3Bacterial Infections (Bacterial Infection)
01/2022 - 01/2018
3Neoplasms (Cancer)
02/2020 - 02/2015
3Alcoholic Liver Diseases (Alcoholic Liver Disease)
07/2019 - 01/2019
2Disease Susceptibility (Diathesis)
01/2024 - 10/2023
2Carcinogenesis
05/2023 - 01/2022
2Non-alcoholic Fatty Liver Disease
01/2022 - 01/2019
2Liver Cirrhosis (Hepatic Cirrhosis)
12/2021 - 01/2016
2AIDS-Related Complex (ARC)
01/2021 - 01/2018
2Chronic Hepatitis C
06/2009 - 11/2005
1Hemolysis
03/2024
1Cytokine Release Syndrome
12/2023
1COVID-19
11/2023
1Coronary Artery Disease (Coronary Atherosclerosis)
11/2023
1Breakthrough Infections
11/2023
1Liver Neoplasms (Liver Cancer)
11/2023
1Obesity
10/2023
1Necrosis
12/2020
1Starvation
02/2020
1Type 2 Diabetes Mellitus (MODY)
08/2019
1Rheumatoid Arthritis
12/2016
1Synovitis
12/2016
1Sepsis (Septicemia)
01/2016
1Multiple Organ Failure (MODS)
01/2016
1Acute Liver Failure (Fulminant Hepatic Failure)
01/2016
1Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
01/2016
1Hepatic Encephalopathy
01/2016
1Alcoholic Fatty Liver
01/2016

Drug/Important Bio-Agent (IBA)

7Antiviral Agents (Antivirals)IBA
01/2018 - 11/2005
5DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2008
4Ethanol (Ethyl Alcohol)IBA
02/2023 - 01/2019
4Hepatitis B e AntigensIBA
04/2013 - 11/2005
3Biomarkers (Surrogate Marker)IBA
11/2023 - 01/2018
3CytokinesIBA
01/2021 - 01/2018
3Interferon-gamma (Interferon, gamma)IBA
12/2020 - 08/2014
2Estrogen ReceptorsIBA
01/2024 - 10/2023
2Alanine Transaminase (SGPT)IBA
10/2023 - 01/2008
2Acetyl Coenzyme A (Acetyl-CoA)IBA
05/2023 - 01/2022
2Protein Isoforms (Isoforms)IBA
08/2015 - 05/2015
2Ribavirin (Virazole)FDA LinkGeneric
06/2009 - 11/2005
2RNA (Ribonucleic Acid)IBA
06/2009 - 01/2008
2Lamivudine (Epivir)FDA Link
09/2008 - 11/2005
1Fatty Acid-Binding ProteinsIBA
03/2024
1Viral VaccinesIBA
11/2023
1Immunoglobulin G (IgG)IBA
11/2023
1mRNA VaccinesIBA
11/2023
1AlbuminsIBA
11/2023
1Interleukin-6 (Interleukin 6)IBA
11/2023
1Lymphotoxin-alpha (Lymphotoxin)IBA
11/2023
1VaccinesIBA
11/2023
1Messenger RNA (mRNA)IBA
11/2023
1Estrogens (Estrogen)FDA Link
10/2023
1Prednisolone (Predate)FDA LinkGeneric
01/2022
1Histones (Histone)IBA
01/2022
1LigandsIBA
01/2021
1CEACAM1 ProteinIBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1CaspasesIBA
01/2021
1LipopolysaccharidesIBA
01/2021
1A-factor (Streptomyces)IBA
01/2021
1Interleukin-22 (IL-22)IBA
12/2020
1interleukin-21 (interleukin 21)IBA
12/2020
1Oxygen (Dioxygen)IBA
02/2020
1Fluorouracil (Carac)FDA LinkGeneric
02/2020
1Irinotecan (Camptosar)FDA LinkGeneric
02/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1Interferon Type IIBA
07/2019
1Linoleic AcidsIBA
01/2019
1Adrenal Cortex Hormones (Corticosteroids)IBA
06/2018
1Interleukin-17 (Interleukin 17)IBA
01/2018
1Interferon LambdaIBA
01/2017
1AmmoniaIBA
01/2016
1Deoxyribonuclease I (Nickase)IBA
01/2016
1Acetaminophen (Paracetamol)FDA LinkGeneric
01/2016
1Interleukin-8 (Interleukin 8)IBA
01/2016
1LeptinIBA
01/2016
1CollagenIBA
01/2016
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2016
1Toll-Like Receptor 4IBA
01/2016
1Toll-Like Receptor 9IBA
01/2016
1OsteopontinIBA
01/2016
1AdipokinesIBA
01/2016
1Pyruvate KinaseIBA
08/2015
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
08/2015
1Apoptosis Regulatory ProteinsIBA
08/2015
1Thymidine KinaseIBA
02/2015

Therapy/Procedure

9Therapeutics
12/2023 - 11/2005
1Liver Transplantation
11/2023
1Immunomodulation
11/2023
1Bioreactors (Bioreactor)
01/2021
1Transjugular Intrahepatic Portasystemic Shunt
01/2021
1Gastric Bypass (Roux-en-Y Gastric Bypass)
08/2019